Background: Although people who smoke cigarettes are overrepresented among hospital inpatients, few are connected with smoking cessation treatment during their hospitalization. Training, accountability for medication use, and monitoring of all patients position pharmacists well to deliver cessation interventions to all hospitalized patients who smoke. Methods: A large Midwestern University hospital implemented a pharmacist-led smoking cessation intervention. A delegation protocol for hospital pharmacy inpatients who smoked cigarettes gave hospital pharmacists the authority to order nicotine replacement therapy (NRT) during hospitalization and upon discharge, and for referral to the Wisconsin Tobacco Quit Line (WTQL) at discharge. Eligible patients received the smoking cessation intervention unless they actively refused (ie, "opt-out"). The program was pilot tested in phases, with pharmacist feedback between phases, and then implemented hospital-wide. Interviews, surveys, and informal mechanisms identified ways to improve implementation and workflows. Results: Feedback from pharmacists led to changes that improved workflow, training and patient education materials, and enhanced adoption and reach. Refining implementation strategies across pilot phases increased the percentage of eligible smokers offered pharmacist-delivered cessation support from 37% to 76%, prescribed NRT from 2% to 44%, and referred to the WTQL from 3% to 32%. Conclusion: Hospitalizations provide an ideal opportunity for patients to make a tobacco quit attempt, and pharmacists can capitalize on this opportunity by integrating smoking cessation treatment into existing inpatient medication reconciliation workflows. Pharmacist-led implementation strategies developed in this study may be applicable in other inpatient settings.
Background: Although people who smoke cigarettes are overrepresented among hospital inpatients, few are connected with smoking cessation treatment during their hospitalization. Training, accountability for medication use, and monitoring of all patients position pharmacists well to deliver cessation interventions to all hospitalized patients who smoke. Methods: A large Midwestern University hospital implemented a pharmacist-led smoking cessation intervention. A delegation protocol for hospital pharmacy inpatients who smoked cigarettes gave hospital pharmacists the authority to order nicotine replacement therapy (NRT) during hospitalization and upon discharge, and for referral to the Wisconsin Tobacco Quit Line (WTQL) at discharge. Eligible patients received the smoking cessation intervention unless they actively refused (ie, "opt-out"). The program was pilot tested in phases, with pharmacist feedback between phases, and then implemented hospital-wide. Interviews, surveys, and informal mechanisms identified ways to improve implementation and workflows. Results: Feedback from pharmacists led to changes that improved workflow, training and patient education materials, and enhanced adoption and reach. Refining implementation strategies across pilot phases increased the percentage of eligible smokers offered pharmacist-delivered cessation support from 37% to 76%, prescribed NRT from 2% to 44%, and referred to the WTQL from 3% to 32%. Conclusion: Hospitalizations provide an ideal opportunity for patients to make a tobacco quit attempt, and pharmacists can capitalize on this opportunity by integrating smoking cessation treatment into existing inpatient medication reconciliation workflows. Pharmacist-led implementation strategies developed in this study may be applicable in other inpatient settings.
Authors: Jody Adams; Alicia A Cymbala; Thomas Delate; Deanna Kurz; Kari L Olson; Morgan Youngblood; Emily Zadvorny Journal: Popul Health Manag Date: 2015-02-03 Impact factor: 2.459
Authors: Cole Buchanan; Georges J Nahhas; Constance Guille; K Michael Cummings; Cameron Wheeler; Erin A McClure Journal: Matern Child Health J Date: 2017-09
Authors: Hilary A Tindle; Robin Daigh; Vivek K Reddy; Linda A Bailey; Judy A Ochs; Marty H Maness; Esa M Davis; Anna E Schulze; Kristi M Powers; Thomas E Ylioja; Hilary B Baca; Jay L Mast; Matthew S Freiberg Journal: Am J Prev Med Date: 2016-07-29 Impact factor: 5.043
Authors: Wendy G Bjornson; David H Gonzales; Catherine J Markin; Noal Clemons; Frances Favela; Trisha M Coleman; Caroline Koudelka; Jodi A Lapidus Journal: Jt Comm J Qual Patient Saf Date: 2016-05
Authors: Chang Yue Chui; Dennis Thomas; Simone Taylor; Billie Bonevski; Michael J Abramson; Eldho Paul; Susan G Poole; Gregory R Weeks; Michael J Dooley; Johnson George Journal: Drug Alcohol Rev Date: 2018-02-07
Authors: Georges J Nahhas; Dianne Wilson; Vince Talbot; Kathleen B Cartmell; Graham W Warren; Benjamin A Toll; Matthew J Carpenter; K Michael Cummings Journal: Nicotine Tob Res Date: 2017-08-01 Impact factor: 4.244
Authors: Paul D Creswell; Danielle E McCarthy; Philip Trapskin; Ann Sheehy; Amy Skora; Robert T Adsit; Mark E Zehner; Timothy B Baker; Michael C Fiore Journal: Am J Health Syst Pharm Date: 2022-06-07 Impact factor: 2.980